Personal Information
Organization / Workplace
Lille France
Industry
Medical / Health Care / Pharmaceuticals
Website
hcs-pharma.com/
About
HCS Pharma is a biotechnology company focused on in vitro R&D, specializing in high content (HCA) and high throughput (HCS) cell imaging screening. HCS Pharma sells products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® extracellular matrix. BIOMIMESYS® 3D culture technology faithfully reproduces the natural microenvironment of cells in 3D, to ensure more predictive results from in vitro studies, to reduce the time and cost of R&D, and animal testing in pharmaceutical, nutraceutical and cosmetic companies.
Tags
biomimesys
3d cell culture
hcs
drugs discovery
liver
high content screening
cell
genotoxicity
drug
ecm
brain
3d culture
toxicity
parkinson
startup
organoids
3d cell
phenotypic screening
hydroscaffold
comet assay
cancer
neurotoxicity
hepg2
biotechnologie
health
hepatocyte
hipscs
organ-on-chip
chip
microenvironment
3d
metabolic
culture 3d
sante
sh-sy5y
virtual reality
visualization
augmented reality
human
statins
ldl
stem cells
drugs
pcsk9
dna damage
biotechnology
elrigfr
phosphorylation
γh2ax
entreprise
biotech
forum labo
prix
forum
steatosis
hcs pharma
cellule
rennes
presse
organs on chip
pancreas
therapy
lung
pluripotent
research
genotypes
ipscs
protection
parkinson's disease
neurosciences
neurology
neurocell3d
drug discovery
biomimesys brain
3d fluorescence
livre
organ
stiffness
breast cancer
hyaluronic acid
bretagne
ouest
investissement
fond
hcspharma
microenvironnement
2019
parís
market
pharmaceutical
hepatocytes
heparg
innovcell3d
strasbourg
hipsc
biofunctionalized
ncardia
ips
scaffold
collagen
adipocyte
3d model
medicament
cell culture
cellular models
comet
genetoxicity
assay
h2ax
micronucleus
big data
future
biology
keratinocyte
"in vitro"
dermocosmetology
fibroblast
primary human keratinocytes
cosmetic
high throughput
genotoxic
high content imaging
e-sante
recherche
public
collaboration
entreprendre
eentreprise
réseau
concours
double strand break
skin
tumor
dna damaging
eukaryotic cells
blood brain barrier
automation
laboratory
scratch assay
cell death effect
anti-cancer drugs
wound healing
dna
micronuclei
biologie
femme
trophée
pharmacie
économie
neuroprotection
telford
phospholipidosis
co-culture
microglia
model
elrig
disease
dijon
afsii
elevator
pitch
presentation
innovation
celenys
2015
biomimetix
salon
dossier
labo
hepatoma
atalante
création
externe
See more
Presentations
(7)Documents
(37)Personal Information
Organization / Workplace
Lille France
Industry
Medical / Health Care / Pharmaceuticals
Website
hcs-pharma.com/
About
HCS Pharma is a biotechnology company focused on in vitro R&D, specializing in high content (HCA) and high throughput (HCS) cell imaging screening. HCS Pharma sells products based on BIOMIMESYS® technology, and develops its own 3D cellular models in its proprietary BIOMIMESYS® extracellular matrix. BIOMIMESYS® 3D culture technology faithfully reproduces the natural microenvironment of cells in 3D, to ensure more predictive results from in vitro studies, to reduce the time and cost of R&D, and animal testing in pharmaceutical, nutraceutical and cosmetic companies.
Tags
biomimesys
3d cell culture
hcs
drugs discovery
liver
high content screening
cell
genotoxicity
drug
ecm
brain
3d culture
toxicity
parkinson
startup
organoids
3d cell
phenotypic screening
hydroscaffold
comet assay
cancer
neurotoxicity
hepg2
biotechnologie
health
hepatocyte
hipscs
organ-on-chip
chip
microenvironment
3d
metabolic
culture 3d
sante
sh-sy5y
virtual reality
visualization
augmented reality
human
statins
ldl
stem cells
drugs
pcsk9
dna damage
biotechnology
elrigfr
phosphorylation
γh2ax
entreprise
biotech
forum labo
prix
forum
steatosis
hcs pharma
cellule
rennes
presse
organs on chip
pancreas
therapy
lung
pluripotent
research
genotypes
ipscs
protection
parkinson's disease
neurosciences
neurology
neurocell3d
drug discovery
biomimesys brain
3d fluorescence
livre
organ
stiffness
breast cancer
hyaluronic acid
bretagne
ouest
investissement
fond
hcspharma
microenvironnement
2019
parís
market
pharmaceutical
hepatocytes
heparg
innovcell3d
strasbourg
hipsc
biofunctionalized
ncardia
ips
scaffold
collagen
adipocyte
3d model
medicament
cell culture
cellular models
comet
genetoxicity
assay
h2ax
micronucleus
big data
future
biology
keratinocyte
"in vitro"
dermocosmetology
fibroblast
primary human keratinocytes
cosmetic
high throughput
genotoxic
high content imaging
e-sante
recherche
public
collaboration
entreprendre
eentreprise
réseau
concours
double strand break
skin
tumor
dna damaging
eukaryotic cells
blood brain barrier
automation
laboratory
scratch assay
cell death effect
anti-cancer drugs
wound healing
dna
micronuclei
biologie
femme
trophée
pharmacie
économie
neuroprotection
telford
phospholipidosis
co-culture
microglia
model
elrig
disease
dijon
afsii
elevator
pitch
presentation
innovation
celenys
2015
biomimetix
salon
dossier
labo
hepatoma
atalante
création
externe
See more